FIELD: medicine, oncology.
SUBSTANCE: invention proposes using chorionic gonadotropin hormone as an agent for inhibition of mitotic activity of cells of Pliss's lymphosarcoma. Early chorionic gonadotropin hormone has been known as agent able to initiate and stimulate multiplication of normal and pathologically changed (but not by tumor process) cells. Invention provides normalization of mitotic activity of cells of Pliss's lymphosarcoma that results to reducing new tumor cells.
EFFECT: valuable medicinal properties of agent.
1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR INHIBITION OF PLISS'S LYMPHOSARCOMA GROWTH | 2004 |
|
RU2263513C1 |
AGENT FOR NORMALIZING OF CD4 T-LYMPHOCYTE LEVEL IN PLISS LYMPHOSARCOMA | 2006 |
|
RU2316338C1 |
METHOD OF PATHOLOGICAL PROCESS MODULATION AND DISORGANISATION OF CELL CARCINOMA CULTURE OF THROAT Hep-2 | 2007 |
|
RU2349600C1 |
METHOD FOR CORRECTION OF CANCER CARRIER LIVER MORPHOLOGICAL STATE | 2004 |
|
RU2271813C1 |
PREPARATION FOR INHIBITING TUMOR GROWTH AND METHOD FOR INHIBITING TUMOR GROWTH IN EXPERIMENT | 2006 |
|
RU2320334C1 |
METHOD OF STIMULATING DYSTROPHIC CHANGES IN TUMOUR TISSUE | 2008 |
|
RU2379070C1 |
AGENT FOR TUMOR TISSUE DESTRUCTION AND CORRECTION OF ORGANISM WITH TUMOR ENDOGENOUS INTOXICATION AND METHOD FOR TUMOR TISSUE DESTRUCTION AND CORRECTION OF ORGANISM WITH TUMOR ENDOGENOUS INTOXICATION | 2006 |
|
RU2319486C1 |
METHOD FOR INHIBITING PLISS LYMPHOSARCOMA GROWTH EXPERIMENTALLY | 2014 |
|
RU2561294C1 |
METHOD FOR TUMOUR GROWTH INHIBITION INDUCTION IN EXPERIMENT | 2012 |
|
RU2499602C1 |
METHOD FOR PREVENTING MALIGNANT PROCESS DEVELOPMENT EXPERIMENTALLY | 2014 |
|
RU2559086C1 |
Authors
Dates
2005-11-10—Published
2004-04-27—Filed